USPTO serial 98251880
CELL ALPHA
Reviewed by CopyMark Law Group
Status 733Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- LORENZO, KATHLEEN H
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with CELL ALPHA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $648*
Plus Government fees of $300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
South San Francisco, CA, US
South San Francisco, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Bobby A. Ghajar
Bobby A. Ghajar COOLEY LLPIP DOCKETING DEPARTMENT1299 PENNSYLVANIA AVENUE, NW, SUITE 700WASHINGTON, DC 20004Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Bioprocessing equipment in the nature of scientific systems for bioprocessing of cellular material and performing fluidic transfers comprised of computer hardware, recorded software, bioprocessing instruments in the nature of pumps, elutriators, magnetic separators, and electroporators, and disposables in the nature of cartridges including mixers, impellers, and bioreactors, all of the aforementioned equipment sold as a unit for the manufacturing of therapeutics and biologics-based drug delivery vehicles; Downloadable computer software for accessing a database featuring information in the medical field, specifically, cell therapy related information; Downloadable software applications for telephones, tablets, computers allowing the access to information and consulting in the field of health; Downloadable software applications for telephones, tablets, computers allowing the access to information, monitoring and management systems for the manufacture of advanced therapy and cell therapy medications; Downloadable databases in the field of manufacture of advanced therapy and cell therapy medications; Scientific and laboratory apparatus and instruments for the manufacturing of autologous and allogeneic biological cell therapies in the nature of laboratory centrifuges, cell sorting apparatus, bioreactors for laboratory use, and parts and fittings for all of the aforesaid goods; Fully integrated laboratory apparatus and computer systems, namely, computer systems comprised of a graphical user interface, processor, and server for use in autologous and allogenic cell therapy manufacturing, and parts and fittings therefor; Downloadable software for the manufacturing of autologous and allogeneic cell therapies; Downloadable software for automating the operations of biotechnological instruments used with manufacturing equipment for biological cell therapies; Downloadable software for the execution, monitoring, analysis of cell therapy manufacturing workflows as well as process development workflows; Downloadable software for the processing, separation, isolation, enrichment, depletion, cell activation, genetic modification, detection, screening, analysis and counting of material, namely, allogeneic and autologous cells; Downloadable software for generating electronic batch records for cell therapies | ACTIVE | — |
| 010 | Medical equipment in the nature of an instrument docking station and a cartridge for the manufacturing of autologous and allogeneic biological cell therapies for medical and non-veterinary purposes, namely, fully integrated system, namely, a fluidic transfer system, chambers for cell processing, and corresponding instrumentation including a fluidic transfer system, chambers for cell processing, and corresponding instrumentation for use in the creation of biological cell therapies for medical purposes; Medical bags and containers in the nature of disposable single-use containers adapted for and sold for solutions used for the manufacturing of autologous and allogeneic biological cell therapies for medical use, namely, bags, pouches, cartridges, namely, for transferring and/or processing of allogeneic or autologous cellular material; rigid and semi-rigid containers for concentrates and solutions in solid or liquid form, all of the aforesaid being for medical use; the foregoing excludes containers that are used to transport or ship temperature-sensitive goods, medicines, pharmaceuticals, and biologics in an insulated- or temperature-controlled manner | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 24, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 23, 2026 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Sep 23, 2026 | EXT4 | SOU EXTENSION 4 FILED | — |
| Sep 23, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 30, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 30, 2026 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Mar 30, 2026 | EXT3 | SOU EXTENSION 3 FILED | — |
| Mar 30, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 27, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 26, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Sep 26, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| Sep 26, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 21, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 20, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Mar 20, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 20, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 1, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 6, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 6, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 17, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 2, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 1, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 1, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 1, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 1, 2024 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jul 1, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 1, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 1, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 18, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 18, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 18, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 15, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 20, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 6, 2023 | NWAP | NEW APPLICATION ENTERED | — |